Prestige Consumer Healthcare Inc (PBH)
72.56
-0.07
(-0.10%)
USD |
NYSE |
Mar 28, 16:00
72.60
+0.04
(+0.06%)
After-Hours: 20:00
Prestige Consumer Healthcare Gross Profit (Quarterly): 157.94M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 157.94M |
September 30, 2023 | 160.02M |
June 30, 2023 | 154.67M |
March 31, 2023 | 153.76M |
December 31, 2022 | 150.40M |
September 30, 2022 | 161.01M |
June 30, 2022 | 160.12M |
March 31, 2022 | 148.86M |
December 31, 2021 | 155.06M |
September 30, 2021 | 157.71M |
June 30, 2021 | 159.01M |
March 31, 2021 | 137.06M |
December 31, 2020 | 138.89M |
September 30, 2020 | 137.66M |
June 30, 2020 | 133.87M |
March 31, 2020 | 143.91M |
December 31, 2019 | 137.50M |
September 30, 2019 | 136.75M |
June 30, 2019 | 134.07M |
March 31, 2019 | 138.25M |
December 31, 2018 | 139.24M |
September 30, 2018 | 137.47M |
June 30, 2018 | 140.62M |
March 31, 2018 | 141.26M |
December 31, 2017 | 147.67M |
Date | Value |
---|---|
September 30, 2017 | 144.10M |
June 30, 2017 | 143.48M |
March 31, 2017 | 130.18M |
December 31, 2016 | 124.55M |
September 30, 2016 | 123.96M |
June 30, 2016 | 121.59M |
March 31, 2016 | 118.25M |
December 31, 2015 | 116.78M |
September 30, 2015 | 119.94M |
June 30, 2015 | 112.24M |
March 31, 2015 | 110.07M |
December 31, 2014 | 111.74M |
September 30, 2014 | 102.54M |
June 30, 2014 | 81.87M |
March 31, 2014 | 78.84M |
December 31, 2013 | 80.47M |
September 30, 2013 | 93.22M |
June 30, 2013 | 83.02M |
March 31, 2013 | 84.59M |
December 31, 2012 | 85.00M |
September 30, 2012 | 90.54M |
June 30, 2012 | 83.60M |
March 31, 2012 | 68.49M |
December 31, 2011 | 55.12M |
September 30, 2011 | 53.91M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
133.87M
Minimum
Jun 2020
161.01M
Maximum
Sep 2022
147.83M
Average
149.63M
Median
Gross Profit (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.838M |
Palatin Technologies Inc | 1.936M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Ampio Pharmaceuticals Inc | -- |